Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
withdrawn125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
completedphase_1

An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

NCT06671405
recruitingphase_1

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

NCT03557619
withdrawnphase_4

Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery

NCT01941134
completednot_applicable

Hormonal Birth Control and the Risk of Acquiring HIV

NCT00006324

Clinical Trials (4)

Showing 4 of 4 trials
NCT06671405Phase 1

An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

Completed
NCT03557619Phase 1

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Recruiting
NCT01941134Phase 4

Changes in Oral Contraceptive Hormones After Gastric Bypass Surgery

Withdrawn
NCT00006324Not Applicable

Hormonal Birth Control and the Risk of Acquiring HIV

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4